Taati Moghadam, M., Amirmozafari, N., Shariati, A., Hallajzadeh, M., Mirkalantari, S., Khoshbayan, A., Masjedian Jazi, F.: How phages overcome the challenges of drug resistant bacteria in clinical infections Volume 13, 45–61 10.2147/IDR.S234353.

Campbell, A.: Conditions for the existence of bacteriophage 15(2), 153 10.2307/2406076.

Krysiak-Baltyn, K., Martin, G.J.O., Stickland, A.D., Scales, P.J., Gras, S.L.: Computational models of populations of bacteria and lytic phage 42(6), 942–968 10.3109/1040841X.2015.1114466. Publisher: Taylor & Francis _eprint: doi: 10.3109/1040841X.2015.1114466

Wedd, C., Yunusov, T., Smith, A., Li, R., Hardo, G., Hunter, M., Majed, R., Fusco, D., Bakshi, S.: Single-cell imaging of the lytic phage life cycle in bacteria. bioRxiv. Pages: 2024.04.11.588870 Section: New Results. DOI: 10.1101/2024.04.11.588870. https://www.biorxiv.org/content/10.1101/2024.04.11.588870v3

Kirzner, S., Barak, E., Lindell, D.: Variability in progeny production and virulence of cyanophages determined at the single-cell level 8(5), 605–613 10.1111/1758-2229.12409. _eprint: https://onlinelibrary.wiley.com/doi/pdf/10.1111/1758-2229.12409

Benzer, S.: RESISTANCE TO ULTRAVIOLET LIGHT AS AN INDEX TO THE REPRODUCTION OF BACTERIOPHAGE 63(1), 59–72 10.1128/jb.63.1.59-72.1952

Denhardt, D.T., Sinsheimer, R.L.: The process of infection with bacteriophage \(\phi\)x174 12(3), 641–646 10.1016/S0022-2836(65)80318–7.

Ellis, E.L., Delbrück, M.: THE GROWTH OF BACTERIOPHAGE 22(3), 365–384.

Dominguez-Mirazo, M., Harris, J.D., Demory, D., Weitz, J.S.: Accounting for cellular-level variation in lysis: implications for virus–host dynamics 15(8), 01376–24 10.1128/mbio.01376-24. Publisher: American Society for Microbiology.

Campos, D., Méndez, V., Fedotov, S.: The effects of distributed life cycles on the dynamics of viral infections 254(2), 430–438 10.1016/j.jtbi.2008.05.035

Santos, S.B., Carvalho, C., Azeredo, J., Ferreira, E.C.: Population dynamics of a salmonella lytic phage and its host: Implications of the host bacterial growth rate in modelling 9(7), 102507 10.1371/journal.pone.0102507. Publisher: Public Library of Science.

Wachenheim, D.E., Patterson, J.A., Ladisch, M.R.: Analysis of the logistic function model: derivation and applications specific to batch cultured microorganisms 86(2), 157–164 10.1016/S0960-8524(02)00149–9.

Leclerc, Q.J., Lindsay, J.A., Knight, G.M.: Modelling the synergistic effect of bacteriophage and antibiotics on bacteria: Killers and drivers of resistance evolution 18(11), 1010746 10.1371/journal.pcbi.1010746. Publisher: Public Library of Science.

Kannoly, S., Oken, G., Shadan, J., Musheyev, D., Singh, K., Singh, A., Dennehy, J.J.: Single-cell approach reveals intercellular heterogeneity in phage-producing capacities 11(1), 02663–21 10.1128/spectrum.02663-21. Publisher: American Society for Microbiology.

Sun, Y.-N., Jusko, W.J.: Transit compartments versus gamma distribution function to model signal transduction processes in pharmacodynamics 87(6), 732–737 10.1021/js970414z.

Dennehy, J.J., Wang, I.-N.: Factors influencing lysis time stochasticity in bacteriophage \(\lambda\) 11(1), 174 10.1186/1471-2180-11-174.

Baker, C.W., Miller, C.R., Thaweethai, T., Yuan, J., Baker, M.H., Joyce, P., Weinreich, D.M.: Genetically determined variation in lysis time variance in the bacteriophage \(\phi\)x174 6(4), 939–955 10.1534/g3.115.024075.

Gibson B, Wilson DJ, Feil E, Eyre-Walker A (1880) The distribution of bacterial doubling times in the wild 285:20180789. https://doi.org/10.1098/rspb.2018.0789

Article  CAS  Google Scholar 

Tuttle, A.R., Trahan, N.D., Son, M.S.: Growth and maintenance of Escherichia coli laboratory strains 1(1), 20 10.1002/cpz1.20.

Cantabella, D., Dolcet-Sanjuan, R., Solsona, C., Vilanova, L., Torres, R., Teixidó, N.: Optimization of a food industry-waste-based medium for the production of the plant growth promoting microorganism pseudomonas oryzihabitans PGP01 based on agro-food industries by-products 32, 00675 10.1016/j.btre.2021.e00675

Yoichi, M., Abe, M., Miyanaga, K., Unno, H., Tanji, Y.: Alteration of tail fiber protein gp38 enables t2 phage to infect Escherichia coli o157:h7 115(1), 101–107 10.1016/j.jbiotec.2004.08.003

Shao, Y., Wang, I.-N.: Bacteriophage adsorption rate and optimal lysis time 180(1), 471–482 10.1534/genetics.108.090100.

Nabergoj, D., Modic, P., Podgornik, A.: Effect of bacterial growth rate on bacteriophage population growth rate 7(2), 00558 10.1002/mbo3.558.

Wang, I.-N.: Lysis timing and bacteriophage fitness 172(1), 17–26 10.1534/genetics.105.045922.

Zaychikova, M., Malakhova, M., Bespiatykh, D., Kornienko, M., Klimina, K., Strokach, A., Gorodnichev, R., German, A., Fursov, M., Bagrov, D., Vnukova, A., Gracheva, A., Kazyulina, A., Shleeva, M., Shitikov, E.: Vic9 mycobacteriophage: the first subcluster b2 phage isolated in russia 15, 1513081 10.3389/fmicb.2024.1513081. Accessed 2025–11-07

Krysiak-Baltyn, K., Martin, G., Gras, S.: Computational modelling of large scale phage production using a two-stage batch process 11(2), 31 10.3390/ph11020031

Montso, P.K., Mlambo, V., Ateba, C.N.: Characterization of lytic bacteriophages infecting multidrug-resistant shiga toxigenic atypical escherichia coli o177 strains isolated from cattle feces 7, 355 10.3389/fpubh.2019.00355

Bull, J.J., Vegge, C.S., Schmerer, M., Chaudhry, W.N., Levin, B.R.: Phenotypic resistance and the dynamics of bacterial escape from phage control 9(4), 94690 10.1371/journal.pone.0094690.

Nielsen, E.I., Viberg, A., Löwdin, E., Cars, O., Karlsson, M.O., Sandström, M.: Semimechanistic pharmacokinetic/pharmacodynamic model for assessment of activity of antibacterial agents from time-kill curve experiments 51(1), 128–136 10.1128/AAC.00604-06.

Rodriguez-Gonzalez, R.A., Leung, C.Y., Chan, B.K., Turner, P.E., Weitz, J.S.: Quantitative models of phage-antibiotic combination therapy 5(1), 10–11280075619 10.1128/msystems.00756-19.

Beauchemin, C.A.A., McSharry, J.J., Drusano, G.L., Nguyen, J.T., Went, G.T., Ribeiro, R.M., Perelson, A.S.: Modeling amantadine treatment of influenza a virus in vitro 254(2), 439–451 10.1016/j.jtbi.2008.05.031

Guedj, J., Dahari, H., Rong, L., Sansone, N.D., Nettles, R.E., Cotler, S.J., Layden, T.J., Uprichard, S.L., Perelson, A.S.: Modeling shows that the NS5a inhibitor daclatasvir has two modes of action and yields a shorter estimate of the hepatitis c virus half-life 110(10), 3991–3996 10.1073/pnas.1203110110.

Woot De Trixhe, X., Krzyzanski, W., Vermeulen, A., Perez-Ruixo, J.J.: Multiscale model of hepatitis c virus dynamics in plasma and liver following combination therapy 10(8), 826–838 10.1002/psp4.12604.